EU clinical trials laws under fire from UK HTA (health technology assessment) expert
This article was originally published in Clinica
The new European legislation on clinical trials will be a major obstacle to researching the effectiveness of medical treatments." So claimed today the UK health technology assessment (HTA) expert Professor Robin Prescott, in his inaugural lecture as head of Edinburgh University's College of Medicine and Veterinary Medicine. The legislation, he said, will hamper academic and clinical research by increasing bureaucracy and costs.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.